Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.99 USD | +0.79% | -5.71% | -29.43% |
13/05 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
09/05 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.43% | 1.12B | |
+5.50% | 111B | |
+11.71% | 106B | |
-12.40% | 22.24B | |
+0.17% | 21.25B | |
-4.92% | 18.97B | |
-35.21% | 18.52B | |
-11.16% | 16.81B | |
+37.49% | 12.54B | |
-24.76% | 8.09B |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- Wedbush Lowers Verona Pharma's Price Target to $23 From $27 Due to Increased Share Count, Keeps Outperform Rating